Core Viewpoint - The legal opinion issued by Beijing Deheng (Hangzhou) Law Firm confirms the legality of the 2024 annual general meeting of Dream Home Group Co., Ltd. held on May 19, 2025, in accordance with relevant laws and regulations [1][4]. Group 1: Meeting Procedures - The meeting was convened by the company's board of directors based on a resolution from the third board meeting held on April 28, 2025 [3]. - The notice for the meeting was published on April 29, 2025, detailing the meeting's agenda, time, and location [3]. - The meeting was conducted both in-person and via online voting, with specific time slots allocated for each voting method [3][4]. Group 2: Attendance and Qualifications - A total of 91 participants attended the meeting, representing 166,210,000 shares, which is 74.6374% of the total voting shares [5]. - Among the attendees, 80 participated through online voting, representing 813,900 shares, or 0.3655% of the total voting shares [4][5]. - The qualifications of the attendees and the convenor were verified and found to be compliant with relevant laws and regulations [4][6]. Group 3: Voting Procedures and Results - The voting process adhered to the agenda outlined in the meeting notice, with no modifications or new proposals introduced [6]. - The voting results indicated that 166,890,500 shares (99.9201%) were in favor of the proposals, while 133,400 shares (0.0799%) were against, and no shares were abstained [7][8]. - The voting results were confirmed to be valid and in compliance with legal requirements [11].

Summary of the Shareholders' Meeting of Guilin Sanjin Pharmaceutical Co., Ltd. Core Viewpoint The shareholders' meeting of Guilin Sanjin Pharmaceutical Co., Ltd. was conducted in compliance with relevant laws and regulations, with all proposed resolutions being approved by the shareholders present. Group 1: Meeting Procedures - The shareholders' meeting was convened by the company's eighth board of directors and announced in advance, detailing the time, location, voting methods, and agenda [1][2][3] - The meeting utilized a combination of on-site voting and online voting, held on May 16, 2025, at the company's conference room in Guilin [2][3] - The legal compliance of the meeting's procedures was verified by the appointed lawyers, confirming adherence to the Company Law and the company's articles of association [4][5] Group 2: Attendance and Voting - A total of 82 shareholders and representatives attended the meeting, representing 417,031,460 shares, which is 70.9758% of the total voting shares [3][4] - Among the attendees, 15 were present at the venue, representing 412,512,257 shares (70.2067%), while 67 participated via online voting, representing 4,519,203 shares (0.7691%) [3] - The attendance included 76 minority shareholders, representing 14,315,780 shares (2.4364%) [3] Group 3: Voting Results - All proposed resolutions were passed with overwhelming support, including the annual report, board and supervisory committee reports, financial statements, and profit distribution plans [6][7][8][9][10] - For the first resolution regarding the 2024 annual report, 417,013,260 shares (99.9956%) voted in favor, with only 5,200 shares (0.0031%) against [6] - The resolutions concerning the remuneration of directors and senior management were also approved, with votes consistently exceeding 99% in favor [11][12][13][14][15] Group 4: Legal Opinion - The lawyers concluded that the meeting's convening, attendance, voting procedures, and results were all legally valid and in accordance with the relevant laws and regulations [23][24]

债券代码：128135 债券简称：洽洽转债 洽洽食品股份有限公司 证券代码：002557 证券简称：洽洽食品 公告编号：2025-041 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 一、会议召开和出席情况 （一）会议召开情况 （1）现场会议时间：2025 年 5 月 16 日（星期五）上午 10:00； （2）网络投票时间：2025 年 5 月 16 日；其中，通过深圳证券交易所交易 系统进行网络投票的具体时间为 2025 年 5 月 16 日上午 9:15—9:25，9:30-11:30， 下午 13:00-15:00；通过深圳证券交易所互联网投票系统进行网络投票的具体时 间为 2025 年 5 月 16 日 9:15-15:00 期间的任意时间。 议室； 本次股东大会的召集、召开与表决程序符合《公司法》、《上市公司股东大 会规则》、《深圳证券交易所股票上市规则》及《公司章程》等法律、法规及规 范性文件的规定。 （二）会议出席情况 高级管理人员以及单独或合计持有公司 5%以上股份的股东以外的其他股东（以 下简称"中小股东"）419 名，代表股 ...

Group 1 - The company held its 14th meeting of the 6th Board of Directors, with all 9 directors present, and the resolutions made were legal and valid [1] - The Board approved the amendment of the company's Articles of Association to comply with relevant laws and regulations, and authorized management to handle the specific matters related to the amendment [1][2] - The Board approved the establishment of a "Temporary Suspension and Exemption System for Information Disclosure" to ensure compliance with information disclosure obligations [2][3] Group 2 - The Board approved the establishment of a "Director Departure Management System" to regulate the management of departing directors and protect shareholder rights [3][4] - The Board approved amendments to various corporate governance-related systems to enhance governance, including renaming certain rules [4] - The Board approved the appointment of Mr. Pang Lin as the new General Manager, replacing Ms. Deng Yan, effective immediately [5] Group 3 - The Board agreed to convene the 2025 First Extraordinary General Meeting of Shareholders [5][6] - All resolutions passed with unanimous support from the directors, with no votes against or abstentions [2][3][4]

Core Viewpoint - The legal opinion letter confirms that the procedures for the 2024 annual general meeting of Shanghai Buke Automation Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [2][12]. Group 1: Meeting Procedures - The board of directors decided to hold the annual general meeting on May 16, 2025, during the ninth meeting of the fifth board on April 23, 2025 [2]. - The meeting notice was published on April 25, 2025, detailing the meeting's time, location, voting methods, and agenda [3]. - The meeting was conducted using a combination of on-site and online voting, with specific time slots for each voting method [4]. Group 2: Attendance and Qualifications - The meeting was convened by the board of directors, meeting legal and regulatory requirements [5]. - Eligible attendees included shareholders registered by May 12, 2025, and their authorized representatives, along with company directors, supervisors, and appointed lawyers [5]. - A total of 43 participants represented 60,980,377 shares, accounting for 72.5956% of the total voting shares [6]. Group 3: Agenda and Voting Results - The agenda included a proposal for the board to authorize stock issuance to specific targets [8]. - The voting results showed that 60,956,783 shares approved the proposals, representing 99.9967% of the votes cast [9][10]. - Among minority investors, 3,793,337 shares voted in favor, indicating a strong majority support [10][11]. Group 4: Conclusion - The legal opinion concludes that all aspects of the meeting, including procedures, qualifications, and voting results, are in compliance with applicable laws and the company's articles of association, rendering the resolutions valid [12].

关于 中农立华生物科技股份有限公司 法律意见书 北京市东城区金宝街 89 号金宝大厦 11 层邮编：100005 电话（Tel）：（86-10）66523388 传真（Fax）：（86-10）66523399 网址（Website）：www.junzejun.com 电子信箱（E-mail） ：jzj@junzejun.com 法律意见书 北京市君泽君律师事务所 关于 中农立华生物科技股份有限公司 法律意见书 致：中农立华生物科技股份有限公司 北京市君泽君律师事务所（以下简称"本所"）受中农立华生物科技股份有限 公司（以下简称"公司"）委托，指派本所律师出席公司 2024 年年度股东大会（以 下简称"本次股东大会"），就本次公司股东大会召集、召开程序、出席本次股东 大会人员的资格以及本次股东大会的表决程序、表决结果进行见证，并出具本法 律意见书。 为出具本法律意见书，本所律师特作出如下声明： 书出具之日前（含当日）已经发生或者存在的事实，履行了法定职责，遵循了勤 勉尽责和诚实信用原则，进行了相应的核查验证，保证本法律意见书所认定的事 实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导 性陈 ...

Core Viewpoint - The legal opinion letter confirms that the 2024 annual general meeting of shareholders for Bozhong Precision Technology Co., Ltd. is scheduled for May 16, 2025, and that the meeting's procedures comply with relevant laws and regulations [1][5]. Group 1: Meeting Procedures - The meeting was approved by the company's third board of directors on April 25, 2025, and was announced to shareholders on April 26, 2025, via the Shanghai Stock Exchange website [2][3]. - The notice included details about the meeting time, location, and the rights of shareholders to attend and vote, including provisions for proxy voting [2][3]. Group 2: Attendance and Qualifications - A total of 64 shareholders (or their proxies) attended the meeting, representing 295,868,227 shares, which is 66.24% of the total voting shares [3][4]. - The qualifications of all attendees, including directors, supervisors, and legal witnesses, were verified to be in compliance with Chinese laws and the company's articles of association [4]. Group 3: Agenda and Voting Results - No new proposals were introduced by shareholders during the meeting, and all agenda items listed in the notice were discussed and voted on [4][5]. - The voting process was conducted through both on-site and online methods, and the results were in accordance with the company's articles of association, confirming the legality and validity of the voting outcomes [5].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、本次股东大会没有出现否决提案。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： （1）现场会议：2025年5月15日（周四）上午10:00 （2）网络投票：通过深圳证券交易所交易系统进行网络投票的具体时间为2025年5月15日上午9:15一 9:25，9:30一11:30，下午13:00一15:00；通过深圳证券交易所互联网投票系统进行网络投票的具体时间 为2025年5月15日上午9:15至下午15:00中的任意时间。 2、会议地点：杭州市萧山区博奥路1658号拓中大厦28层3号会议室 4、召集人：公司董事会 5、主持人：公司董事长袁仁军先生 6、会议的召开符合《公司法》《深圳证券交易所股票上市规则》《上市公司股东大会规则》及《公司 章程》等法律、法规及规范性文件的规定。 （二）会议出席情况 1、股东出席的总体情况： 通过现场和网络投票的股东171人，代表股份377,655,43 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301130 证券简称：西点药业 公告编号：2025-038 吉林省西点药业科技发展股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 通过网络投票的股东35人，代表股份4,375,528股，占公司有表决权股份总数的5.7200％ 现场会议时间：2025年5月15日（星期四）14:00 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年5月15日9:15一 9:25，9:30一11:30和13:00一15:00；通过深圳证券交易所互联网投票系统投票的具体时间为：2025年5月 15日9:15至15:00 2、会议召开地点：吉林省磐石经济开发区西点大街777号公司会议室 3、会议召开方式：现场表决和网络表决相结合的方式 4、会议召集人：吉林省西点药业科技发展股份有限公司 ...

Financial Data and Key Metrics Changes - The meeting confirmed that a quorum was present with over 5,300,000 shares represented, which constitutes a majority of the total shares entitled to vote [8] - The proposals for the election of directors and the ratification of PricewaterhouseCoopers as the independent registered public accounting firm were approved [12][13] Business Line Data and Key Metrics Changes - No specific financial data or key metrics related to individual business lines were discussed in the meeting Market Data and Key Metrics Changes - No specific market data or key metrics were provided during the meeting Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and the ratification of the accounting firm, indicating a stable governance structure, but did not provide insights into specific strategic initiatives or competitive positioning Management Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during the meeting Other Important Information - The final report of the inspector of election will be filed as part of the meeting record, and final voting results will be reported within four business days [13] Q&A Session Summary Question: Were there any questions submitted during the meeting? - There were no questions submitted during the meeting, and the Q&A session concluded without addressing any inquiries [14]